Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...